The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumour mutational burden as a predictive and prognostic biomarker in locally advanced and recurrent/metastatic adenoid cystic carcinoma.
 
Karan Patel
No Relationships to Disclose
 
Samuel Rack
No Relationships to Disclose
 
Hitesh Mistry
Employment - SystemsForecastingUK
Leadership - SystemsForecastingUK
Stock and Other Ownership Interests - SystemsForecastingUK
Consulting or Advisory Role - SystemsForecastingUK
Patents, Royalties, Other Intellectual Property - OncoBayes Ltd.; SystemsForecastingUK
Travel, Accommodations, Expenses - SystemsForecastingUK
 
Emily Heathcote
No Relationships to Disclose
 
Guy Betts
No Relationships to Disclose
 
Kevin Joseph Harrington
Honoraria - Arch Oncology (Inst); AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Codiak Biosciences (Inst); Inzen Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Oncolys BioPharma (Inst); Pfizer (Inst); Replimune (Inst); Scenic Biotech
Consulting or Advisory Role - Arch Oncology (Inst); AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Inzen Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Oncolys BioPharma (Inst); Replimune (Inst)
Speakers' Bureau - BMS (Inst); Merck Serono (Inst); MSD (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Replimune (Inst)
 
Robert Metcalf
Honoraria - Bristol-Myers Squibb; MSD; Sanofi
Consulting or Advisory Role - Achilles Therapeutics; Aptus Clinical; Ayala Pharmaceuticals; Bayer; OxSonics Therapeutics; PCI Biotech